isotretinoin

It is used in the treatment of severe forms of acne or acne with a risk of permanent scarring, especially when other methods (e.g., antibiotics) have not been effective. It works by reducing sebum secretion by the skin glands and preventing the formation of pustules and papules.

Form: capsules, soft gelatin

ATC: D10BA01

Manufacturer: Almirall Hermal GmbH

It is used in the treatment of severe forms of acne or acne with a risk of permanent scarring, especially when other methods (e.g., antibiotics) have not been effective. It works by reducing sebum secretion from the skin glands and preventing the formation of pustules.

Form: capsules, soft gelatin

ATC: D10BA01

Manufacturer: Almirall Hermal GmbH

The medicinal product is used for the treatment of severe forms of acne (nodular, conglobate, or with a risk of permanent scarring) in adults and adolescents over 12 years of age, for whom other treatment methods have not been effective.

Form: capsules, soft gelatin

ATC: D10BA01

Manufacturer: GAP SA

The medicine is used to treat severe forms of acne (nodular, conglobate, or with a risk of permanent scarring) in adults and adolescents over 12 years of age who have completed puberty, and where previous treatment with other medicines has not been effective.

Form: capsules, soft gelatin

ATC: D10BA01

Manufacturer: GAP SA

The medicinal product is intended for the treatment of severe forms of acne (nodular, conglobate, or with a risk of permanent scarring) that do not respond to standard antibacterial or topical treatments.

Form: capsules, soft gelatin

ATC: D10BA01

Manufacturer: Pierre Fabre Medicament

It is used in the treatment of severe forms of acne (e.g., nodular, conglobate acne, or acne with a risk of permanent scarring) that do not respond to standard antibacterial treatment.

Form: capsules, soft gelatin

ATC: D10BA01

Manufacturer: Catalent France Beinheim SA, Catalent Germany Eberbach GmbH, Catalent Germany Schorndorf GmbH

The medicine is intended for the treatment of severe forms of acne (such as nodular, conglobate, or acne with a risk of permanent scarring) that do not respond to standard antibiotic treatment or topical medications.

Form: capsules, soft gelatin

ATC: D10BA01

Manufacturer: Catalent France Beinheim SA, Catalent Germany Eberbach GmbH, Catalent Germany Schorndorf GmbH

The medicine is intended for the treatment of severe forms of acne (nodular, conglobate, or with a risk of permanent scarring) that do not respond to standard antibiotic treatment or topical medications.

Form: capsules, soft gelatin

ATC: D10BA01

Manufacturer: Pierre Fabre Iberica, S.A.

It is used in the treatment of severe forms of acne (e.g., nodular, conglobate acne, or acne with a risk of permanent scarring) that do not respond to standard antibiotic treatment or topical medications.

Form: capsules, soft gelatin

ATC: D10BA01

Manufacturer: Pierre Fabre Iberica, S.A.

The medicine is intended for the treatment of severe forms of acne (nodular, conglobate, or with a risk of permanent scarring) that do not respond to standard antibiotic treatment or topical medications.

Form: capsules, soft gelatin

ATC: D10BA01

Manufacturer: Pierre Fabre Medicament

The medicinal product is intended for the treatment of severe forms of acne (nodular, conglobate, or with a risk of permanent scarring) that do not respond to standard antibiotic treatment or topical medications.

Form: capsules, soft gelatin

ATC: D10BA01

Manufacturer: Pierre Fabre Iberica, S.A.

The medicinal product is used to treat severe forms of acne (nodular, conglobate, or with a risk of permanent scarring) in adults and adolescents over 12 years of age, for whom other treatment methods have not been effective.

Form: capsules, soft gelatin

ATC: D10BA01

Manufacturer: GAP SA

The medicinal product is intended for the treatment of severe forms of acne (nodular, conglobate, or with a risk of permanent scarring) in adults and adolescents over 12 years of age, for whom other treatment methods have not been effective.

Form: capsules, soft gelatin

ATC: D10BA01

Manufacturer: GAP SA

The medicine is used to treat severe forms of acne (e.g., papulopustular acne, nodular acne, or acne with a risk of permanent scarring) in adults and adolescents over 12 years of age who have passed puberty.

Form: capsules, soft gelatin

ATC: D10BA01

Manufacturer: Pharmathen Investments Group Limited

The medicinal product is intended for the treatment of severe forms of acne (e.g., papulopustular acne, nodular acne, or acne with a risk of permanent scarring) in adults and adolescents over 12 years of age who have passed puberty.

Form: capsules, soft gelatin

ATC: D10BA01

Manufacturer: Pharmathen Investments Group Limited

The medicine is used to treat severe forms of acne (e.g., papulopustular acne, nodular acne, or acne with a risk of permanent scarring) in adults and adolescents over 12 years of age (post-puberty), when other treatment methods have not been effective.

Form: capsules, soft gelatin

ATC: D10BA01

Manufacturer: Pharmathen Investments Group Limited

The medicine is used to treat severe forms of acne (e.g., papulopustular acne, nodular acne, or acne with a risk of permanent scarring) in adults and adolescents over 12 years of age who have already passed puberty.

Form: capsules, soft gelatin

ATC: D10BA01

Manufacturer: Pharmathen Investments Group Limited

The medicinal product is used in the treatment of severe forms of acne (e.g., papulopustular acne, nodular acne, or acne with a risk of permanent scarring) in adults and in adolescents over 12 years of age who have passed puberty.

Form: capsules, soft gelatin

ATC: D10BA01

Manufacturer: Pharmathen Investments Group Limited

The medicinal product is used to treat severe forms of acne (e.g., papulopustular acne, nodular acne, or acne with a risk of permanent scarring) in adults and adolescents over 12 years of age, where other treatment methods have not been effective.

Form: capsules, soft gelatin

ATC: D10BA01

Manufacturer: Pharmathen Investments Group Limited

The medicinal product is used to treat severe forms of acne (e.g., papulopustular acne or acne with a risk of permanent scarring) in adults and adolescents over 12 years of age, for whom other treatment methods have not been effective.

Form: capsules, soft gelatin

ATC: D10BA01

Manufacturer: Pharmathen Investments Group Limited

The medicinal product is used for the treatment of mild to moderate acne vulgaris.

Form: gel

ATC: D10AD04

Manufacturer: Ziaja Ltd. - Pharmaceutical Production Plant Sp. z o.o.